Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:54 PM
Ignite Modification Date:
2025-12-24 @ 10:54 PM
NCT ID:
NCT04412369
Eligibility Criteria:
Inclusion Criteria:
* Patients \>18 years old
* Confirmed COVID-19 infection AND Troponin I elevation \>99th percentile of upper reference limit OR new-onset heart failure OR unexplained cardiac symptoms
* Able to give written, informed consent
Exclusion Criteria:
* Women of child-bearing potential not using adequate contraception
* Contra-indication to MRI scanning
* Contrast allergy or contrast-nephropathy
* Chronic kidney disease (eGFR \<30 mL/min/1.73 m2)
* Previous myocardial infarction
* Uncontrolled atrial fibrillation
* Uncontrolled chronic inflammatory disease
* Severe lymphopenia (\<0.2 x109/L)
* Treatment with immunomodulatory therapies within the last month (excluding inhaled or topical steroid therapy)
* Any medical condition, in the opinion of the investigator, that prevents the participant from lying flat during scanning, or from participating in the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT04412369
Study Brief:
Protocol Section:
NCT04412369